QNTM Quantum Biopharma Ltd. - Class B Subordinate Voting Shares
QNTM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
QNTM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
QNTM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
1 analysts · 2026-08-16Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2025 | $-0.71 | — | — |
| Dec. 31, 2020 | $-22.04 | $-92.82 | 70.8% |
| Sept. 30, 2020 | $-89.05 | $-47.40 | -41.6% |
| June 30, 2020 | $-43.55 | $-73.59 | 30.0% |
| Dec. 31, 2019 | $-177.45 | $-94.15 | -83.3% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 28 filers · $1.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-2 vs prior Q) | 3 (-1 vs prior Q) | 7 (+1 vs prior Q) | 5 (+3 vs prior Q) | +139K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| AdvisorShares Investments LLC | $736,902 | 203,564 | 52.76% | Shares |
| Platform Technology Partners | $148,840 | 41,116 | 10.66% | Shares |
| UBS Group AG | $107,572 | 29,716 | 7.70% | Shares |
| Steward Partners Investment Advisory, LLC | $100,929 | 27,881 | 7.23% | Shares |
| JANE STREET GROUP, LLC | $74,315 | 20,529 | 5.32% | Shares |
| CITADEL ADVISORS LLC | $57,424 | 15,863 | 4.11% | Shares |
| Marex Group Ltd | $48,638 | 13,436 | 3.48% | Shares |
| Mariner, LLC | $36,200 | 10,000 | 2.59% | Shares |
| LANARK FINANCIAL, INC. | $25,340 | 7,000 | 1.81% | Shares |
| OSAIC HOLDINGS, INC. | $22,787 | 6,295 | 1.63% | Shares |
| Global Retirement Partners, LLC | $10,860 | 3,000 | 0.78% | Shares |
| TUCKER ASSET MANAGEMENT LLC | $8,132 | 1,114 | 0.58% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $4,594 | 1,209 | 0.33% | Shares |
| Farther Finance Advisors, LLC | $3,620 | 1,000 | 0.26% | Shares |
| Atlantic Union Bankshares Corp | $3,620 | 1,000 | 0.26% | Shares |
| MORGAN STANLEY | $2,172 | 600 | 0.16% | Shares |
| ROYAL BANK OF CANADA | $2,000 | 446 | 0.14% | Shares |
| Cetera Trust Company, N.A | $905 | 250 | 0.06% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $688 | 190 | 0.05% | Shares |
| WELLS FARGO & COMPANY/MN | $544 | 150 | 0.04% | Shares |
| SBI Securities Co., Ltd. | $286 | 79 | 0.02% | Shares |
| GROUP ONE TRADING LLC | $123 | 34 | 0.01% | Shares |
| Rockefeller Capital Management L.P. | $109 | 30 | 0.01% | Shares |
| Federation des caisses Desjardins du Quebec | $104 | 29 | 0.01% | Shares |
| Activest Wealth Management | $54 | 15 | 0.00% | Shares |
| TD Waterhouse Canada Inc. | $20 | 6 | 0.00% | Shares |
| Purpose Unlimited Inc. | $4 | 1 | 0.00% | Shares |
| CITIGROUP INC | $4 | 1 | 0.00% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Malone Wealth Ventures LLC ×4 filings | June 23, 2025 | 17.80% | Amendment | — | SEC |
| Dr. Raza Bokhari (2) | April 11, 2022 | — | Initial filing | — | SEC |
| First Republic Capital Corporation, Fortius Research and Trading Corporation, Anthony Durkacz, Richard Goldstein, Andrew Durkacz, Gloria Durkacz, Xorax Family Trust, Legacy Family Trust, Zeeshan Saeed, Rehan Saeed, Zachary Dutton | April 1, 2021 | — | Initial filing | — | SEC |
| Dr. Raza Bokhari ×2 filings | Feb. 22, 2021 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.